KLK3 and prostate cancer: We evaluated risk variables in two large controlled prostate cancer trials that included PSA screening: PLCO (Prostate Lung Colon Ovarian Screening Trial) and SELECT (Selenium and Vitamin E Cancer Prevention Trial) [13, 14].